MiMedx Group, Inc. (OTC BB: MDXG)is focused on developing biomaterial-based products for application in the musculoskeletal specialties. The company intends to leverage their experienced management team to commercializes medical technologies by facilitating their progression through the proper regulatory approval processes, arranging for reliable and cost-effective manufacturing, and delivering these products to markets throughout the world. For further information, visit the Company’s web site at www.mimedx.com.
- 17 years ago
QualityStocks
MiMedx Group, Inc. (OTC BB: MDXG)
Tags Rodman & Renshaw
Related Post
-
Perpetuals.com Ltd. (NASDAQ: PDC) Completes BayesShield(TM) AI Pilot, Reporting 92% Block Rate on Losing Retail Crypto Trades
The BayesShield AI system analyzed a full year of real retail trading data to validate…
-
QualityStocksNewsBreaks – SPACSphere Acquisition Corp. (NASDAQ: SSACU) Closes $172.5 Million Initial Public Offering
SPACSphere Acquisition (NASDAQ: SSACU) announced the closing of its initial public offering of 17,250,000 units…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Featured by RADIO + TELEVISION BUSINESS REPORT for ADIO Engagement Platform and Real-Time Bias Meter
Datavault AI (NASDAQ: DVLT) is highlighted in the Winter 2026 issue (p. 27) of RADIO + TELEVISION BUSINESS REPORT, which examines…